4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-23-017636
Director sold 19,232 shares at an average $36.98 ($711,199)
- Director acquired 72,016 shares (option exercise)
- Director gave up 3,778 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
PIMSTONE SIMON N. · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-07 | Exercise or conversion : show line 1 in the form | +41,152 | $2.68 | $110,287 | 47,152 | D |
| 2023-03-07 | Shares withheld for taxes : show line 2 in the form | −2,160 | $37.13 | $80,201 | 44,992 | D |
| 2023-03-07 | Sale : show line 3 in the form | −10,990 | $37.01 | $406,740 | 34,002 | D |
| 2023-03-07 | Exercise or conversion : show line 4 in the form | +30,864 | $2.59 | $79,938 | 64,866 | D |
| 2023-03-07 | Shares withheld for taxes : show line 5 in the form | −1,618 | $37.13 | $60,076 | 63,248 | D |
| 2023-03-07 | Sale : show line 6 in the form | −8,242 | $36.94 | $304,459 | 55,006 | D |
| Open-market sales · 19,232 sh · avg $36.98 · $711,199 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-07 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −41,152 | 0 | D |
| 2023-03-07 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −30,864 | 0 | D |
Loading xslF345X03/doc4.xml…